These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7289432)

  • 1. [Prostaglandin E-2 in cyanotic heart defects in newborn (author's transl)].
    Beitzke A
    Klin Padiatr; 1981 Sep; 193(5):385-9. PubMed ID: 7289432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y; Bosi G; Stijns M; Vliers A
    Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.
    Thanopoulos BD; Andreou A; Frimas C
    Eur J Pediatr; 1987 May; 146(3):279-82. PubMed ID: 3474149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of prostaglandin E2 in management of transposition of great arteries before balloon atrial septostomy.
    Beitzke A; Suppan CH
    Br Heart J; 1983 Apr; 49(4):341-4. PubMed ID: 6572529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostaglandin E1: effect on blood gases in infants with cyanotic congenital heart disease (author's transl)].
    Schöber JG; Kellner M; Christian I
    Klin Padiatr; 1977 Sep; 189(5):365-9. PubMed ID: 21323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants].
    Dymnicka S; Bielińska B; Ereciński J; Machnowski W
    Pediatr Pol; 1981 Oct; 56(10):1243-8. PubMed ID: 7199703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostaglandin E1 therapy in infants with cyanotic congenital heart malformations: hemodynamic and angiographic findings (author's transl)].
    Schumacher G; Mocellin R; Schöber JG; Kellner M; Bühlmeyer K
    Klin Padiatr; 1978 Sep; 190(5):465-73. PubMed ID: 568198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary atresia and transposition of the great arteries. Monitoring of the transcutaneous oxygen tension during palliative measures in two cases.
    Nielsen G; Oxhøj H
    Biotelem Patient Monit; 1982; 9(1):45-8. PubMed ID: 6179551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.
    Neutze JM; Starling MB; Elliott RB; Barratt-Boyes BG
    Circulation; 1977 Feb; 55(2):238-41. PubMed ID: 64317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of prostaglandin E1 on the hemodynamics in newborn infants with pulmonary atresia (author's transl)].
    Mocellin R; Sauer U; Schumacher G; Kellner M; Schöber JG
    Z Kardiol; 1978 Aug; 67(8):572-7. PubMed ID: 695809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgery in newborns and infants with cyanotic cardiac malformations: indication and technique of emergency operations and urgent early surgical interventions (author's transl)].
    Schmidt-Habelmann P; Gams E; Sauer U; Kunkel R; Meisner H; Struck E; Sebening F
    Herz; 1978 Feb; 3(1):55-61. PubMed ID: 721032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transposition of the great arteries: natural history and indications for surgery after balloon-atrioseptostomy (author's transl)].
    Beitzke A; Sauer U; Mocellin R; Döhlemann C; Bühlmeyer K
    Z Kardiol; 1977 Jan; 66(1):28-34. PubMed ID: 835321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostaglandin E2 in newborns with congenital heart disease].
    Schlemmer M; Khoss A; Salzer HR; Wimmer M
    Z Kardiol; 1982 Jul; 71(7):452-7. PubMed ID: 6958133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications to the surgical treatment of patients with "simple" transposition of the great arteries. Analysis of 302 cases surgically treated according to mustard's technique (author's transl)].
    Piccoli GP; De Leval MR; Taylor JF; Macartney FJ; Stark J
    G Ital Cardiol; 1981; 11(12):2048-55. PubMed ID: 7346305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2-dimensional and Doppler echocardiography during atrioseptostomy using the Rashkind method. Alternative umbilical approach in the newborn infant].
    Ibarra Henríquez O; Olalla Antolín JJ; Rissech Payret M; Mortera Pérez C
    An Esp Pediatr; 1988 Sep; 29(3):211-5. PubMed ID: 3057977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2.
    Olley PM; Coceani F
    Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML
    Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.